name:-0.04609203338623
name:-0.038203001022339
name:-0.025002956390381
Ardelyx, Inc. Patent Filings

Ardelyx, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ardelyx, Inc..The latest application filed is for "compounds useful for treating gastrointestinal tract disorders".

Company Profile
34.59.71
  • Ardelyx, Inc. - Fremont CA
  • ARDELYX, INC - Fremont CA US
  • Ardelyx, Inc. - Freemont CA
  • ARDELYX, INC.; - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Compounds Useful For Treating Gastrointestinal Tract Disorders
App 20220306610 - DRAGOLI; Dean ;   et al.
2022-09-29
Substituted 4-phenyl Pyridine Compounds As Non-systemic Tgr5 Agonists
App 20220306672 - Lewis; Jason G. ;   et al.
2022-09-29
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 11,318,129 - Charmot , et al. May 3, 2
2022-05-03
Glycyrrhetinic Acid Derivatives For Use In Treating Hyperkalemia
App 20220106354 - Dragoli; Dean ;   et al.
2022-04-07
Compounds useful for treating gastrointestinal tract disorders
Grant 11,242,337 - Dragoli , et al. February 8, 2
2022-02-08
Hormone Receptor Modulators For Treating Metabolic Mutagenic And Fibrotic Conditions And Disorders
App 20210380585 - Chao; Jianhua
2021-12-09
Inhibitors of NHE-mediated antiport
Grant 11,147,884 - Dotsenko , et al. October 19, 2
2021-10-19
Isoxazolyl-carbonyloxy Azabicyclo[3.2.1]octanyl Compounds As Fxr Activators
App 20210300927 - Chao; Jianhua ;   et al.
2021-09-30
Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activators
Grant 11,091,482 - Chao , et al. August 17, 2
2021-08-17
Nhe3-binding Compounds And Methods For Inhibiting Phosphate Transport
App 20210186953 - Carreras; Christopher ;   et al.
2021-06-24
Glycyrrhetinic Acid Derivatives For Treating Hyperkalemia
App 20210163524 - Luehr; Gary ;   et al.
2021-06-03
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
Grant 10,968,246 - Lewis , et al. April 6, 2
2021-04-06
NHE3-binding compounds and methods for inhibiting phosphate transport
Grant 10,940,146 - Carreras , et al. March 9, 2
2021-03-09
Hormone Receptor Modulators For Treating Metabolic Conditions And Disorders
App 20210017177 - Chao; Jianhua ;   et al.
2021-01-21
Methods For Inhibiting Phosphate Transport
App 20200368223 - King; Andrew J.
2020-11-26
Hormone receptor modulators for treating metabolic conditions and disorders
Grant 10,793,568 - Chao , et al. October 6, 2
2020-10-06
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt
App 20200268741 - Charmot; Dominique ;   et al.
2020-08-27
Substituted 4-phenyl Pyridine Compounds As Non-systemic Tgr5 Agonists
App 20200062795 - Lewis; Jason G. ;   et al.
2020-02-27
Compounds And Methods For Inhibiting Phosphate Transport
App 20200038475 - Charmot; Dominique ;   et al.
2020-02-06
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 10,543,207 - Charmot , et al. Ja
2020-01-28
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt
App 20190374533 - CHARMOT; Dominique ;   et al.
2019-12-12
Inhibitors Of Nhe-mediated Antiport
App 20190374649 - DOTSENKO; Irina ;   et al.
2019-12-12
Compounds Useful For Treating Gastrointestinal Tract Disorders
App 20190359599 - DRAGOLI; Dean ;   et al.
2019-11-28
Isoxazolyl-carbonyloxy Azabicyclo[3.2.1]octanyl Compounds As Fxr Activators
App 20190308973 - Chao; Jianhua ;   et al.
2019-10-10
Nhe3-binding Compounds And Methods For Inhibiting Phosphate Transport
App 20190275028 - Carreras; Christopher ;   et al.
2019-09-12
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
Grant 10,392,413 - Lewis , et al. A
2019-08-27
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 10,385,024 - Bell , et al. A
2019-08-20
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 10,376,481 - Bell , et al. A
2019-08-13
Hormone Receptor Modulators For Treating Metabolic Conditions And Disorders
App 20190233420 - Chao; Jianhua ;   et al.
2019-08-01
NHE3-binding compounds and methods for inhibiting phosphate transport
Grant 10,272,079 - Carreras , et al.
2019-04-30
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20190062279 - BELL; Noah ;   et al.
2019-02-28
Compositions and methods for treating hyperkalemia
Grant 9,919,006 - Charmot , et al. March 20, 2
2018-03-20
Compositions And Methods For Treating Hyperkalemia
App 20180064751 - Charmot; Dominique ;   et al.
2018-03-08
Compositions and methods for treating hyperkalemia
Grant 9,867,848 - Charmot , et al. January 16, 2
2018-01-16
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20170368004 - BELL; Noah ;   et al.
2017-12-28
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20170340623 - CHARMOT; Dominique ;   et al.
2017-11-30
Compositions And Methods For Treating Hyperkalemia
App 20170196903 - Charmot; Dominique ;   et al.
2017-07-13
Substituted 4-phenyl Pyridine Compounds As Non-systemic Tgr5 Agonists
App 20170174718 - LEWIS; Jason Gustaf ;   et al.
2017-06-22
Compositions And Methods For Treating Hyperkalemia
App 20170173072 - Charmot; Dominique ;   et al.
2017-06-22
Compositions and methods for treating hyperkalemia
Grant 9,655,921 - Charmot , et al. May 23, 2
2017-05-23
Compounds And Methods For Inhibiting Phosphate Transport
App 20170037010 - Lewis; Jason G. ;   et al.
2017-02-09
Pharmaceutical compositions for treating hyperkalemia
Grant 9,549,947 - Charmot , et al. January 24, 2
2017-01-24
Pharmaceutical compositions for treating hyperkalemia
Grant 9,545,425 - Charmot , et al. January 17, 2
2017-01-17
Compositions And Methods For Treating Hyperkalemia
App 20160346318 - Charmot; Dominique ;   et al.
2016-12-01
Compositions and methods for treating hyperkalemia
Grant 9,433,640 - Charmot , et al. September 6, 2
2016-09-06
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder
Grant 9,408,840 - Bell , et al. August 9, 2
2016-08-09
Pharmaceutical Compositions For Treating Hyperkalemia
App 20160175345 - Charmot; Dominique ;   et al.
2016-06-23
Compositions And Methods For Treating Hyperkalemia
App 20160175344 - Charmot; Dominique ;   et al.
2016-06-23
Pharmaceutical Compositions For Treating Hyperkalemia
App 20160175346 - Charmot; Dominique ;   et al.
2016-06-23
Compounds and methods for inhibiting phosphate transport
Grant 9,301,951 - Lewis , et al. April 5, 2
2016-04-05
Compounds and methods for inhibiting phosphate transport
Grant 9,289,429 - Lewis , et al. March 22, 2
2016-03-22
Compounds and methods for inhibiting phosphate transport
Grant 9,289,430 - Lewis , et al. March 22, 2
2016-03-22
Nhe3-binding Compounds And Methods For Inhibiting Phosphate Transport
App 20160067242 - Carreras; Christopher ;   et al.
2016-03-10
Compounds and methods for inhibiting phosphate transport
Grant 9,278,102 - Lewis , et al. March 8, 2
2016-03-08
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20150336892 - LEADBETTER; Michael ;   et al.
2015-11-26
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20150299131 - BELL; Noah ;   et al.
2015-10-22
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorder
App 20150190389 - BELL; Noah ;   et al.
2015-07-09
Compounds And Methods For Inhibiting Phosphate Transport
App 20150164905 - Lewis; Jason G. ;   et al.
2015-06-18
Compounds And Methods For Inhibiting Phosphate Transport
App 20150164904 - Lewis; Jason G. ;   et al.
2015-06-18
Compounds And Methods For Inhibiting Phosphate Transport
App 20150164876 - Lewis; Jason G. ;   et al.
2015-06-18
Compounds And Methods For Inhibiting Phosphate Transport
App 20150157637 - Lewis; Jason G. ;   et al.
2015-06-11
Non-systemic Tgr5 Agonists
App 20150148311 - Lewis; Jason G. ;   et al.
2015-05-28
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 9,006,281 - Bell , et al. April 14, 2
2015-04-14
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 8,969,377 - Bell , et al. March 3, 2
2015-03-03
Compounds and methods for inhibiting phosphate transport
Grant 8,916,569 - Lewis , et al. December 23, 2
2014-12-23
Compounds and methods for inhibiting phosphate transport
Grant 8,815,908 - Lewis , et al. August 26, 2
2014-08-26
Compounds and methods for inhibiting phosphate transport
Grant 8,815,910 - Lewis , et al. August 26, 2
2014-08-26
Compounds and methods for inhibiting phosphate transport
Grant 8,809,339 - Lewis , et al. August 19, 2
2014-08-19
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20140107074 - BELL; Noah ;   et al.
2014-04-17
Compounds And Methods For Inhibiting Phosphate Transport
App 20140023611 - Lewis; Jason G. ;   et al.
2014-01-23
Compounds And Methods For Inhibiting Phosphate Transport
App 20130336918 - Lewis; Jason G. ;   et al.
2013-12-19
Compounds And Methods For Inhibiting Phosphate Transport
App 20130336920 - Lewis; Jason G. ;   et al.
2013-12-19
Compounds And Methods For Inhibiting Phosphate Transport
App 20130336921 - Lewis; Jason G. ;   et al.
2013-12-19
Compounds And Methods For Inhibiting Phosphate Transport
App 20130336919 - Lewis; Jason G. ;   et al.
2013-12-19
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20130274285 - BELL; Noah ;   et al.
2013-10-17
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Grant 8,541,448 - Charmot , et al. September 24, 2
2013-09-24
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders
App 20120263670 - Charmot; Dominique ;   et al.
2012-10-18
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed